MediQuo provides a secure platform for medical professionals to attend patients by chat, call or videoconference, with professional tools to facilitate telematic communication. The company reports 1.2 million registered users and handles about 1.5 million consultations annually. It has commercial agreements with Asisa, Centros de Atención Primaria Capsbe (CatSalut), GSK, Novo Nordisk, AIG and Inmedical. MediQuo expected to reach break even at the close of 2022 and projects €20 million in sales by 2027. The recently raised funds are intended to consolidate growth in Spain and accelerate internationalization across Latin America. The product is positioned in the HealthTech/telemedicine segment and targets both patient-facing consultations and partnerships with healthcare organisations. MediQuo offers a WhatsApp‑inspired telemedicine app and web platform that lets validated health professionals consult with patients by chat, voice, or video. The company launched in November 2017 and focuses its growth on Spain and Latin America, serving both consumers and B2B2C clients such as insurers, hospitals, pharmaceutical companies and employers. MediQuo reports more than 800,000 registered users, over 1 million consultations in one year, a 4.6/5 rating from over 10,000 reviews, and has 1,500 validated professionals using MediQuo PRO. In 2020 the company launched mediQuo PRO, a SaaS tool for professionals available as app and web, and says sales grew 700% that year. Current plans with the new funding include commercial expansion, consolidating product vision, developing a high‑value app and web version for professionals, and signing further B2B2C agreements to deepen market position. mediQuo is a Barcelona, Spain-based eHealth app that provides a platform to manage medical consultations. By the end of 2019 the app had recorded 940,000 medical consultations and 570,000 mobile downloads. The company closed a €2m funding round from investors in the health sector, various venture capital investors and family offices. It intends to use the funds to continue expanding operations and its business reach. mediQuo will soon launch mediQuo PRO to allow doctors and health professionals to manage consultations online for both their own patients and the app's users. With mediQuo PRO the company aims to reach 14,000 health professionals and to manage 1.5 million patient consultations within the next 15 months. The business was founded by Albert Castells, José López and Guillem Serra and is also led by Bruno Cuevas. Mediquo offers a medical chat application that lets patients contact licensed doctors across specialties with unlimited messages and typical responses in under two minutes. The app was founded by Guillem Serra, José López and Albert Castells and aims to provide medical attention from the smartphone around the clock. It operates in Spain, Peru, Argentina and Chile, has begun offering services in the United States, and has not ruled out expansion to Asia (China). Since launch in Spain the app has been downloaded by more than 30,000 users and logged over 145,000 medical consultations. The company’s stated goal is to be a "medical friend" in users' pockets, delivering rapid access to care. Mediquo recently closed a venture capital financing to support its growth and international rollout. MediQuo operates a medical chat application that lets users contact licensed doctors across specialties directly from their phones. After downloading the app, patients can message doctors unlimitedly and typically receive responses in under two minutes. The company was founded by Guillem Serra, José López and Albert Castells; Guillem Serra is CEO and co-founder. MediQuo's stated mission is to bring medicine to everyone, provide medical orientation or second opinions, and recover the traditional proximity between patients and physicians. The startup closed a financing round of €3 million to support its growth and service expansion. The company is based in Barcelona and the funding was reported by El Referente.

Total raised

$12M

Funding rounds

5

Latest round

Equity

Latest activity

Apr 2023